ATACNCT05334940
Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved 2 years 4 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Aug 31, 2025 to Dec 31, 2027
- Eligibility criteria expanded, about 6 words
- Trial status changed: Unknown → Recruiting
- Secondary endpoints: details revised at 7 of 11 entries
- Minor Changed Registry marked status Unknown; last known: Recruiting
- Minor Trial status: Recruiting to Unknownv4
- Notable Start date changed from estimate of Sep 1, 2022 to Dec 8, 2022v3
- Notable Start date: May 1, 2022 to Sep 1, 2022
- Primary and study completion dates: Apr 1, 2025 to Aug 31, 2025
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Comorbidity Food Allergy
Timeframe: 3 years
Comorbidity Atopic Dermatitis
Timeframe: 3 years
Comorbidity Bronchial Asthma
Timeframe: 3 years
Comorbidity Chronic rhinosinusitis with nasal polyps
Timeframe: 3 years
Comorbidity Chronic Spontaneous Urticaria
Timeframe: 3 years
Comorbidity Eosinophilic Esophagitis
Timeframe: 3 years
Comorbidity Allergic Rhinitis
Timeframe: 3 years
Secondary (11)
Food Allergy Severity
Atopic Dermatitis Severity
Allergic Rhinitis Severity
Bronchial Asthma Severity FVC
Bronchial Asthma Severity FEV1
Show 6 moreShow less
Bronchial Asthma Severity FEF25-75
Chronic Spontaneous Urticaria LQ (CUQ2oL)
Chronic Spontaneous Urticaria Severity (AECT)
Chronic Spontaneous Urticaria Severity (UAS7)
Eosinophilic Esophagitis Severity and/or LQ
Chronic Rhinosinusitis with Nasal Polyposis Severity
Arms and interventions
Atopic disorders
Patients with at least 2 atopic disorders who are eligible for systemic therapy with biologics
Other: not applicable, observational study
Sites
1 site in 1 country
- Charité - Universitätsmedizin BerlinBerlin, Germany